2019
DOI: 10.1016/j.medmal.2019.04.347
|View full text |Cite
|
Sign up to set email alerts
|

Acceptabilité du remplacement des associations fixes d’antirétroviraux (ARV) par des traitements comportant des génériques d’analogues nucléosidiques

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles